Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 3;7:52. doi: 10.1038/s41598-017-00104-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Effect of 15a treatment on the amount of monocytes. (a) At 2 hours after injection and two weeks of treatment, 15a reduced the relative amount of circulating CCR2⁺ monocytes (defined as CD11b⁺Ly6G^low cells). (b) At 18 hours after the last injection (after 4 weeks of treatment), the number of circulating CD11b⁺Ly6G^lowCCR2⁺ cells was significantly reduced by 15a treatment. (c) The ratio of patrolling monocytes and pro-inflammatory monocytes was significantly increased upon treatment with 15a (*P < 0.05, **P < 0.01, ***P < 0.001). Graphs shown are representative from one experiment with n = 5 per group in panel (a) and n = 6 per group in panels (b) and (c).